Evidence map›Paper›PMID 37991487›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2024

Cell-free hemoglobin triggers macrophage cytokine production via TLR4 and MyD88.

Kaitlyn R Schaaf, Stuart R Landstreet, Sangami Pugazenthi, Emily Y Qian, Nathan D Putz, Tatiana Siderova, Allison M Owen, Julia K Bohannon, Lorraine B Ware, Julie A Bastarache and 1 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kaitlyn R SchaafDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-8473-6642
Stuart R LandstreetDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Sangami PugazenthiDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Emily Y QianDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Nathan D PutzDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Tatiana SiderovaDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Allison M OwenDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0001-5623-4891
Julia K BohannonDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States.
Lorraine B WareDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-9429-4702
Julie A BastaracheDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0003-0458-6507
Ciara M ShaverDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States.ORCID 0000-0002-5677-0288
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDSR35HL150783 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2020 to 2026
$4.6M
Immunogenomic analysis of donor lung injury and its impact on clinical outcomes after lung transplantationR01HL160551 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ciara M Shaver · 2022 to 2026
$3.4M
Protection Against Nosocomial Infections After Severe Burn Injury Through Trained ImmunityR35GM141927 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julia K. Bohannon · 2021 to 2026
$2.4M
Haptoglobin 2 variant and endothelial glycocalyx shedding in sepsis-induced ARDSR01HL158906 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2021 to 2024
$2.3M
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunctionR01HL126671 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, JULIE ANNE · 2015 to 2019
$2.0M
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in SepsisR01HL164937 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2022 to 2025
$1.7M
Mechanisms of airspace inflammation caused by cell-free hemoglobin during ARDSK08HL136888 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHAVER, CIARA M · 2017 to 2021
$858k
Potential Protective Mechanisms of Tissue Factor in Acute Lung InjuryI01BX002288 · VA · VETERANS HEALTH ADMINISTRATION · PI BASTARACHE, JULIE ANNE · 2018 to 2021
–
BLRD VA I01 BX002288NCATS NIH HHS UL1 TR002243NHLBI NIH HHS K08 HL136888NHLBI NIH HHS R01 HL126671NHLBI NIH HHS R01 HL158906NHLBI NIH HHS R01 HL160551NHLBI NIH HHS R01 HL164937NHLBI NIH HHS R35 HL150783NIGMS NIH HHS R35 GM141927
6 · The paper itself

Abstract

Cell-free hemoglobin (CFH) is elevated in the airspace of patients with acute respiratory distress syndrome (ARDS) and is sufficient to cause acute lung injury in a murine model. However, the pathways through which CFH causes lung injury are not well understood. Toll-like receptor 4 (TLR4) is a mediator of inflammation after detection of damage- and pathogen-associated molecular patterns. We hypothesized that TLR4 signaling mediates the proinflammatory effects of CFH in the airspace. After intratracheal CFH, BALBc mice deficient in TLR4 had reduced inflammatory cell influx into the airspace [bronchoalveolar lavage (BAL) cell counts, median TLR4 knockout (KO): 0.8 × 10

Indexed as

Acute Lung InjuryRespiratory Distress SyndromeAdaptor Proteins, Signal TransducingAnimalsCytokinesHemoglobinsHumansInflammationInterleukin-6MacrophagesMiceMice, Inbred C57BLMice, KnockoutMyeloid Differentiation Factor 88Toll-Like Receptor 4Tumor Necrosis Factor-alphaAdaptor Proteins, Signal TransducingCytokinesHemoglobinsInterleukin-6Myeloid Differentiation Factor 88TLR4 protein, humanToll-Like Receptor 4Tumor Necrosis Factor-alphaacute lung injurycell-free hemoglobininflammationmacrophagesTLR4

Identifiers

PMID37991487
PMCPMC11279742
OpenAlexW4388913575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.